FDA-Device2022-04-27Class II
Matrix Clinical Solution At-Home COVID-19 Test
Matrix Medical Network
Hazard
Due to COVID-19 Test not being authorized for home sample collection.
Sold states
U.S.: AL, AZ, CA, CO, CT, DC, DE, FL, GA, LA, MA, MD, MI, MN, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, and WV. O.U.S.: N/A
Affected count
3,226 kits
Manufactured in
9201 E Mountain View Rd, Scottsdale, AZ, United States
Products
Matrix Clinical Solution At-Home COVID-19 Test
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0947-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief